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To the Editor: 
 
A recent Editorial in Nature Genetics (38, 851; 2006) highlighted the potential of 
genomic research in Arab countries for understanding monogenic diseases and early-
onset genetic disorders of childhood but stated that "it is unlikely that consanguinity 
contributes significantly to polygenic and multifactorial diseases once socioeconomic 
variables have been controlled for." We think that this statement is inaccurate and 
could serve to discourage a very important line of genomic research in which Arab 
countries are well placed to contribute. The Editorial statement is consistent neither 
with population genetic principles nor with the results of a large body of research in 
both experimental organisms and humans1,2. 
 
There are several reasons why consanguinity should be expected to have a significant 
effect on polygenic traits influencing human health1-3. First, published empirical 
evidence in animals and humans consistently reports inbreeding effects on numerous 
multifactorial traits that are both fitness related1,2,3,5 and post-reproductive (refs. 6,7, 
and A.V. Hill, personal communication). In the case of complex late-onset traits, 
inbreeding depression is predicted to be greater than for early-onset traits under at 
least one plausible model3. In humans, there is growing evidence for adverse effects 
of inbreeding on resistance to infectious diseases, including tuberculosis and hepatitis 
B virus (A.V. Hill, personal communication), and on traits such as blood pressure and 
several common late-onset diseases, after controlling for socioeconomic factors6,7. 
Second, inbreeding effects associated with homozygosity at disease susceptibility loci 
could result in epistatic effects that jointly impair the capacity to adapt to 
environmental risks, including infectious diseases5. Third, there is now evidence that 
heterozygote advantage at loci such as the major histocompatibility complex, which 
may be maintained by balancing selection, could be reduced by consanguinity8. 
Finally, the association between socioeconomic factors and consanguinity in societies 
such as Tunisia and Croatia are highly complex and dependent on many factors, 
including cultural context and gender9. 
 
The favorable secular trends in health and life expectancy in human populations 
worldwide during recent decades coincides both with improved economic growth and 
development and with massive urbanization, admixture and outbreeding on a global 
scale. These observed health gains are not solely explained by socioeconomic factors. 
Therefore, until this issue is better understood, the possible contribution of 
consanguinity and outbreeding to polygenic traits and complex human diseases should 
not be dismissed, and the Arab countries are well-placed to be at the forefront of this 
endeavor. 
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